Clinical trial
Carboplatin and Paclitaxel in Treating Patients With Locally Recurrent or…
NCT00003206 · Eastern Cooperative Oncology Group, Other · Completed
Key facts
| NCT number | NCT00003206 |
|---|---|
| Title | Carboplatin and Paclitaxel in Treating Patients With Locally Recurrent or Metastatic Nasopharyngeal Cancer |
| Official title | A Phase II Trial of Carboplatin Plus Paclitaxel in the Treatment of Locally Recurrent or Metastatic Nasopharyngeal Carcinoma |
| Lead sponsor | Eastern Cooperative Oncology Group, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Head and Neck Cancer |
| Intervention type | Drug |
| Interventions | carboplatin, paclitaxel |
| Start date | Oct 6, 1999 |
| Primary completion | Jul 1, 2001 |
| First posted | Jun 16, 2004 |
| Last update posted | Jun 15, 2023 |
| Countries | South Africa, United States |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: